Y Natkunam

Summary

Publications

  1. pmc Immunoblot analysis of CD34 expression in histologically diverse neoplasms
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
    Am J Pathol 156:21-7. 2000
  2. ncbi request reprint Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
    Mod Pathol 14:686-94. 2001
  3. ncbi request reprint Angiocentric lymphomas (lymphomatous vasculitis)
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, CA 94305, USA
    Semin Diagn Pathol 18:67-77. 2001
  4. ncbi request reprint Natural killer cell precursor acute lymphoma/leukemia presenting in an infant
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Calif 94305, USA
    Arch Pathol Lab Med 125:413-8. 2001
  5. ncbi request reprint Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, CA 94305, USA
    J Cutan Pathol 27:392-9. 2000
  6. ncbi request reprint Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course
    S Mraz-Gernhard
    Departments of Dermatology, Pathology, and Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Oncol 19:2179-88. 2001
  7. ncbi request reprint A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia
    A M Cherry
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Cancer Genet Cytogenet 129:155-60. 2001
  8. ncbi request reprint Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Clin Lymphoma 2:185-7. 2001
  9. ncbi request reprint Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
    I S Lossos
    Department of Medicine, Division of Oncology, Stanford University Medical Center, CA 94305-5151, USA
    Blood 98:945-51. 2001
  10. doi request reprint Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder
    O Hatton
    Program in Immunology, Department of Surgery Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 13:883-90. 2013

Collaborators

Detail Information

Publications10

  1. pmc Immunoblot analysis of CD34 expression in histologically diverse neoplasms
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
    Am J Pathol 156:21-7. 2000
    ..These results show that the observed immunohistological reactivity with anti-CD34 antibodies is due to the expression of the CD34 protein and not to shared epitopes on unrelated proteins...
  2. ncbi request reprint Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
    Mod Pathol 14:686-94. 2001
    ....
  3. ncbi request reprint Angiocentric lymphomas (lymphomatous vasculitis)
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, CA 94305, USA
    Semin Diagn Pathol 18:67-77. 2001
    ..The salient clinicopathologic features of natural killer and natural killer-like T-cell lymphomas together with the inherent difficulty of their identification and an integrated approach to their diagnosis are outlined in this article...
  4. ncbi request reprint Natural killer cell precursor acute lymphoma/leukemia presenting in an infant
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Calif 94305, USA
    Arch Pathol Lab Med 125:413-8. 2001
    ..This case emphasizes the need for a strong index of suspicion to recognize this rare entity and to distinguish it from solid tumors and other hematolymphoid neoplasms that occur in infancy...
  5. ncbi request reprint Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, CA 94305, USA
    J Cutan Pathol 27:392-9. 2000
    ..Lymphomas with co-expression of CD56 and CD30 are extremely rare and the significance of this co-expression is unknown...
  6. ncbi request reprint Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course
    S Mraz-Gernhard
    Departments of Dermatology, Pathology, and Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Oncol 19:2179-88. 2001
    ..To describe and identify the clinical and pathologic features of prognostic significance for natural killer (NK) and NK-like T-cell (NK/T-cell) lymphoma presenting in the skin...
  7. ncbi request reprint A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia
    A M Cherry
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Cancer Genet Cytogenet 129:155-60. 2001
    ..Here, we describe a patient with AML-M4 and a previously unreported rearrangement involving the AML1 locus and an unknown locus on the short arm of chromosome 1 at 1p32...
  8. ncbi request reprint Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab
    Y Natkunam
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Clin Lymphoma 2:185-7. 2001
    ..We present an unusual case of a 30-year-old man with recurrent TCRBCL arising from lymphocyte-predominant Hodgkin's disease with remarkable response to treatment with the anti-CD20 antibody, rituximab...
  9. ncbi request reprint Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
    I S Lossos
    Department of Medicine, Division of Oncology, Stanford University Medical Center, CA 94305-5151, USA
    Blood 98:945-51. 2001
    ..High BCL-6 mRNA expression should be considered a new favorable prognostic factor in DLBCL and should be used in the stratification and the design of risk-adjusted therapies for patients with DLBCL. (Blood. 2001;98:945-951)..
  10. doi request reprint Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder
    O Hatton
    Program in Immunology, Department of Surgery Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 13:883-90. 2013
    ..Taken together, our data indicate that Syk activates PI3K/Akt signaling which is required for survival of EBV+ B cell lymphomas. PI3K/Akt signaling may be a promising therapeutic target for PTLD, and other EBV-associated malignancies...